Venus Medtech (Hangzhou) Inc.
VMTHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $187,137 | $240,113 | $230,720 | $235,763 |
| % Growth | -22.1% | 4.1% | -2.1% | – |
| Cost of Goods Sold | $49,149 | $54,127 | $48,960 | $47,807 |
| Gross Profit | $137,988 | $185,986 | $181,760 | $187,956 |
| % Margin | 73.7% | 77.5% | 78.8% | 79.7% |
| R&D Expenses | $120,928 | $160,351 | $180,834 | $230,200 |
| G&A Expenses | $54,785 | $69,451 | $76,575 | $75,893 |
| SG&A Expenses | $154,189 | $184,255 | $206,837 | $209,430 |
| Sales & Mktg Exp. | $100,459 | $114,077 | $130,989 | $142,566 |
| Other Operating Expenses | $0 | -$17,934 | $0 | $0 |
| Operating Expenses | $275,117 | $326,672 | $387,671 | $439,630 |
| Operating Income | -$137,129 | -$140,686 | -$205,911 | -$251,674 |
| % Margin | -73.3% | -58.6% | -89.2% | -106.7% |
| Other Income/Exp. Net | -$1,435 | -$395,958 | -$7,670 | -$113,327 |
| Pre-Tax Income | -$138,564 | -$536,644 | -$213,581 | -$365,001 |
| Tax Expense | $3,792 | -$28,096 | -$4,756 | -$2,160 |
| Net Income | -$134,772 | -$507,820 | -$206,487 | -$353,566 |
| % Margin | -72% | -211.5% | -89.5% | -150% |
| EPS | -0.31 | -1.16 | -0.47 | -0.81 |
| % Growth | 73.3% | -146.8% | 42% | – |
| EPS Diluted | -0.31 | -1.16 | -0.47 | -0.81 |
| Weighted Avg Shares Out | 437,898 | 437,897 | 437,898 | 437,898 |
| Weighted Avg Shares Out Dil | 437,897 | 437,897 | 437,897 | 437,897 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $10,350 | $0 | $2,926 |
| Interest Expense | $7,172 | $16,647 | $0 | $0 |
| Depreciation & Amortization | $14,947 | $67,948 | $43,161 | $40,734 |
| EBITDA | -$122,182 | -$450,207 | -$162,750 | -$208,730 |
| % Margin | -65.3% | -187.5% | -70.5% | -88.5% |